Benzinga | Aug 14, 2020 08:11AM EDT

Outlook Therapeutics Q3 Adj. EPS $(0.11) Up From $(0.24) YoY

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.11) per share. This is a 54.17 percent increase over losses of $(0.24) per share from the same period last year.